← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2015Last known activity
Jan 3, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT07171411CollaboratorN/AJan 3, 2024
- NCT04911673Overall official - principal investigatorN/AJan 30, 2021
- NCT04911673Reponsible party - principal investigatorN/AJan 30, 2021
- NCT04911673Lead sponsorN/AJan 30, 2021
- NCT02824393Reponsible party - principal investigatorEarly Phase 1Mar 3, 2017
- NCT02824393Lead sponsorEarly Phase 1Mar 3, 2017
- NCT02619695CollaboratorPhase 4Jun 1, 2015
- NCT02491879CollaboratorPhase 4Jun 1, 2015
Details
- Last known activity
- Jan 3, 2024